AURORA, ONTARIO–(Marketwired – Dec 18, 2013) – Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) (“Helix”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, announces that its Annual General and Special Meeting (the “Meeting”) was held today as scheduled.
- 0 Comments
- FY2014